Terez, Margie V.
HRN: 09-06-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/17/2022
05/23/2022
IV
500 Mg
Q8
Abdominal Pain
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes